Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (101-110 of 321) with videos related to

Pageof 33
Sort By:
European Journal of Haematology|December 23, 2004
Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafnessShinji Kunishima, Tadashi Matsushita, Motoaki Shiratsuchi, et al.
Biochemical and Biophysical Research Communications|July 9, 2004
Expression cloning of oligomerization-activated genes with cell-proliferating potency by pseudotype retrovirus vectorAkihiro Abe, Nobuhiko Emi, Tadaharu Kanie, et al.
European Journal of Haematology|April 9, 2005
Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experienceMasamitsu Yanada, Momoko Suzuki, Kohei Kawashima, et al.
Cancer Letters|May 10, 2011
MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cellsSyunsuke Noguchi, Takashi Mori, Yuki Hoshino, et al.
Cancer Science|November 13, 2003
Antitumor effect of arsenic trioxide in murine xenograft modelMariko Kito, Kenji Matsumoto, Naoko Wada, et al.
International Journal of Hematology|June 21, 2008
Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia: trisomy 10 may appear as an additional changeMoritaka Gotoh, Yuko Sasaki, Tomotaka Iguchi, et al.
Journal of Molecular Histology|April 25, 2012
Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiationTomohiro Itoh, Yuko Ito, Yoshinori Ohtsuki, et al.
Plos One|October 8, 2013
Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in miceKiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, et al.
Blood|February 28, 2009
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significanceJunji Hiraga, Akihiro Tomita, Takumi Sugimoto, et al.
Cancer Immunology, Immunotherapy : CII|October 22, 2021
Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trialToru Kiguchi, Masaki Yamaguchi, Naoki Takezako, et al.
Pageof 33

Showing results (101-110 of 321) with videos related to

Sort By:
Pageof 33
European Journal of Haematology|December 23, 2004
Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafnessShinji Kunishima, Tadashi Matsushita, Motoaki Shiratsuchi, et al.
Biochemical and Biophysical Research Communications|July 9, 2004
Expression cloning of oligomerization-activated genes with cell-proliferating potency by pseudotype retrovirus vectorAkihiro Abe, Nobuhiko Emi, Tadaharu Kanie, et al.
European Journal of Haematology|April 9, 2005
Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experienceMasamitsu Yanada, Momoko Suzuki, Kohei Kawashima, et al.
Cancer Letters|May 10, 2011
MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cellsSyunsuke Noguchi, Takashi Mori, Yuki Hoshino, et al.
Cancer Science|November 13, 2003
Antitumor effect of arsenic trioxide in murine xenograft modelMariko Kito, Kenji Matsumoto, Naoko Wada, et al.
International Journal of Hematology|June 21, 2008
Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia: trisomy 10 may appear as an additional changeMoritaka Gotoh, Yuko Sasaki, Tomotaka Iguchi, et al.
Journal of Molecular Histology|April 25, 2012
Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiationTomohiro Itoh, Yuko Ito, Yoshinori Ohtsuki, et al.
Plos One|October 8, 2013
Functionally deregulated AML1/RUNX1 cooperates with BCR-ABL to induce a blastic phase-like phenotype of chronic myelogenous leukemia in miceKiyoko Yamamoto, Shinobu Tsuzuki, Yosuke Minami, et al.
Blood|February 28, 2009
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significanceJunji Hiraga, Akihiro Tomita, Takumi Sugimoto, et al.
Cancer Immunology, Immunotherapy : CII|October 22, 2021
Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trialToru Kiguchi, Masaki Yamaguchi, Naoki Takezako, et al.
Pageof 33